Review Article| Volume 344, ISSUE 5, P391-394, November 2012

Infections May be Causal in the Pathogenesis of Atherosclerosis


      There is a universal lack of exposure response between degree of lipid lowering and the outcome in clinical and angiographic trials questioning the current view on atherogenesis. However, there are numerous observations and experiments suggesting that microorganisms may play a causal role. A clue is the fact that the lipoproteins constitute an innate immune system by binding and inactivating microorganisms and their toxic products through formation of circulating complexes. Their size may increase in the presence of hyperhomocysteinemia because homocysteine reacts with low-density lipoprotein (LDL) to form homocysteinylated LDL aggregates. Autoantibodies against homocysteinylated or oxidized LDL may also enhance the aggregation. Because of the high extracapillary pressure, such aggregates may obstruct arterial vasa vasorum producing ischemia and cell death within the arterial wall leading to the creation of a vulnerable plaque. The many epidemiological observations, clinical findings and laboratory experiments that conflict with the cholesterol hypothesis are in good accordance with ours.

      Key Indexing Terms

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to The American Journal of the Medical Sciences
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Reis S.E.
        • Holubkov R.
        • Conrad Smith A.J.
        • WISE Investigators
        • et al.
        Coronary microvascular dysfunction is highly prevalent in women with chest pain in the absence of coronary artery disease: results from the NHLBI WISE study.
        Am Heart J. 2001; 141: 735-741
        • McCully K.S.
        Vascular pathology of homocysteinemia: implications for the pathogenesis of arteriosclerosis.
        Am J Pathol. 1969; 56: 111-128
        • Ravnskov U.
        Is atherosclerosis caused by high cholesterol?.
        Q J Med. 2002; 95: 397-403
        • Hecht H.S.
        • Superko H.R.
        • Smith L.K.
        • et al.
        Relation of coronary artery calcium identified by electron beam tomography to serum lipoprotein levels and implications for treatment.
        Am J Cardiol. 2001; 87: 406-412
        • Schatz I.J.
        • Masaki K.
        • Yano K.
        • et al.
        Cholesterol and all-cause mortality in elderly people from the Honolulu Heart Program: a cohort study.
        Lancet. 2001; 358: 351-355
        • Onder G.
        • Landi F.
        • Volpato S.
        • et al.
        Serum cholesterol levels and in-hospital mortality in the elderly.
        Am J Med. 2003; 115: 265-271
        • Ulmer H.
        • Kelleher C.
        • Diem G.
        • et al.
        Why Eve is not Adam: prospective follow-up in 149650 women and men of cholesterol and other risk factors related to cardiovascular and all-cause mortality.
        J Womens Health (Larchmt). 2004; 13: 41-53
        • Schupf N.
        • Costa R.
        • Luchsinger J.
        • et al.
        Relationship between plasma lipids and all-cause mortality in nondemented elderly.
        J Am Geriatr Soc. 2005; 53: 219-226
        • Anderson K.M.
        • Castelli W.P.
        • Levy D.
        Cholesterol and mortality. 30 years of follow-up from the Framingham study.
        JAMA. 1987; 257: 2176-2180
        • Johnsen S.P.
        • Larsson H.
        • Tarone R.E.
        • et al.
        Risk of hospitalization for myocardial infarction among users of rofecoxib, celecoxib, and other NSAIDs: a population-based case-control study.
        Arch Intern Med. 2005; 165: 978-984
        • Hippisley-Cox J.
        • Coupland C.
        Risk of myocardial infarction in patients taking cyclo-oxygenase-2 inhibitors or conventional non-steroidal anti-inflammatory drugs: population based nested case-control analysis.
        BMJ. 2005; 330: 1366-1372
        • Ravnskov U.
        • McCully K.S.
        Vulnerable plaque formation from obstruction of Vasa vasorum by homocysteinylated and oxidized lipoprotein aggregates complexed with microbial remnants and LDL autoantibodies.
        Ann Clin Lab Sci. 2009; 39: 3-16
        • Piconi S.
        • Trabattoni D.
        • Luraghi C.
        • et al.
        Treatment of periodontal disease results in improvements in endothelial dysfunction and reduction of the carotid intima-media thickness.
        FASEB J. 2009; 23: 1196-1204
        • Enos W.F.
        • Holmes R.H.
        • Beyer J.
        Coronary disease among United States soldiers killed in action in Korea; preliminary report.
        JAMA. 1953; 152: 1090-1093
        • Blaha F.
        [Observations on the pathogenesis of arteriosclerosis from an experience in a concentration camp.
        ] Ćas Lék Ćes [J Czech Physicians]. 1958; 97: 86-89
        • Liuba P.
        • Persson J.
        • Luoma J.
        • et al.
        Acute infections in children are accompanied by oxidative modification of LDL and decrease of HDL cholesterol, and are followed by thickening of carotid intima-media.
        Eur Heart J. 2003; 24: 515-521
        • Fabricant C.G.
        • Fabricant J.
        • Litrenta M.M.
        • et al.
        Virus-induced atherosclerosis.
        J Exp Med. 1978; 148: 335-340
        • Damy S.B.
        • Higuchi M.L.
        • Timenetsky J.
        • et al.
        Mycoplasma pneumoniae and/or Chlamydophila pneumoniae inoculation causing different aggravations in cholesterol-induced atherosclerosis in apoE KO male mice.
        BMC Microbiol. 2009; 9: 194-201
        • Birck M.M.
        • Pesonen E.
        • Odermarsky M.
        • et al.
        Infection-induced coronary dysfunction and systemic inflammation in piglets are dampened in hypercholesterolemic milieu.
        Am J Physiol Heart Circ Physiol. 2011; 300: H1595-601
        • Ott S.J.
        • El Mokhtari N.E.
        • Musfeldt M.
        • et al.
        Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease.
        Circulation. 2006; 113: 929-937
        • Shi Y.
        • Tokunaga O.
        Chlamydia pneumoniae and multiple infections in the aorta contribute to atherosclerosis.
        Pathol Int. 2002; 52: 755-763
        • Ravnskov U.
        High cholesterol may protect against infections and atherosclerosis.
        Q J Med. 2003; 96: 927-934
        • Sijbrands E.J.
        • Westendorp R.G.
        • Defesche J.C.
        • et al.
        Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study.
        BMJ. 2001; 322: 1019-1023
        • Apostolou F.
        • Gazi I.F.
        • Kostoula A.
        • et al.
        Persistence of an atherogenic lipid profile after treatment of acute infection with Brucella.
        J Lipid Res. 2009; 50: 2532-2539
        • Gidding S.S.
        • Stone N.J.
        • Bookstein L.C.
        • et al.
        Month-to-month variability of lipids, lipoproteins, and apolipoproteins and the impact of acute infection in adolescents.
        J Pediatr. 1998; 133: 242-246
        • Pletcher M.J.
        • Bibbins-Domingo K.
        • Liu K.
        • et al.
        Nonoptimal lipids commonly present in young adults and coronary calcium later in life: the CARDIA (Coronary Artery Risk Development in Young Adults) study.
        Ann Intern Med. 2010; 153: 137-146
        • Naruszewicz M.
        • Mirkiewicz E.
        • Olszewski A.J.
        • et al.
        Thiolation of low-density lipoprotein by homocysteine thiolactone causes increased aggregation and altered interaction with cultured macrophages.
        Nutr Metab Cardiovasc Dis. 1994; 4: 70-77
        • McCully K.S.
        Chemical pathology of homocysteine. IV. Excitotoxicity, oxidative stress, endothelial dysfunction, and inflammation.
        Ann Clin Lab Sci. 2009; 3: 219-232
        • Higuchi M.L.
        • Gutierrez P.S.
        • Bezerra H.G.
        • et al.
        Comparison between adventitial and intimal inflammation of ruptured and nonruptured atherosclerotic plaques in human coronary arteries.
        Arq Bras Cardiol. 2002; 79: 20-24
        • Higuchi M.L.
        • Sambiase N.
        • Palomino S.
        • et al.
        Detection of Mycoplasma pneumoniae and Chlamydia pneumoniae in ruptured atherosclerotic plaques.
        Braz J Med Biol Res. 2000; 33: 1023-1026
        • Maiellaro K.
        • Taylor W.R.
        The role of the adventitia in vascular inflammation.
        Cardiovasc Res. 2007; 75: 640-648
        • Nicolaou G.
        • Goodall A.H.
        • Erridge C.
        Diverse bacteria promote macrophage foam cell formation via toll-like receptor-dependent lipid body biosynthesis.
        J Atheroscler Thromb. 2012; 19: 137-148
        • Higuchi M.L.
        • Santos M.H.
        • Roggério A.
        • et al.
        A role for archaeal organisms in development of atherosclerotic vulnerable plaques and myxoid matrices.
        Clinics (Sao Paulo). 2006; 61: 473-478